Urinary Exosomal MiR-193a Can Be a Potential Biomarker for the Diagnosis of Primary Focal Segmental Glomerulosclerosis in Children

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2017 Mar 2

PMID 28246603

Citations 34

Authors

Zhibin Huang

Yong Zhang

Jianhua Zhou

Yu Zhang

Affiliations

Soon will be listed here.

Abstract

. Glomerular upregulation of miR-193a has been detected in primary focal segmental glomerulosclerosis (FSGS) but not in other glomerular diseases. We aimed to isolate exosomes from urine of children with primary FSGS and to assess the diagnostic potential of urinary exosomal miR-193a for primary FSGS. . The first morning urine samples were collected from children with primary FSGS ( = 8) and minimal change disease (MCD, = 5). Isolated urinary exosomes were confirmed by electron microscopy and Western blotting. Urinary exosomal microRNA was extracted, and the expression levels of exosomal miR-193a were quantified by real-time PCR. The diagnosis value of urinary exosomal miR-193a levels for primary FSGS was evaluated by ROC analysis. . The isolated vesicles were qualitatively compatible with exosomes. The levels of urinary exosomal miR-193a were significantly higher in children with primary FSGS than those in children with MCD. Moreover, the area under the ROC for the diagnosis of primary FSGS using urinary exosomal miR-193a was 0.85. . A significant increase in the levels of urinary exosomal miR-193a in primary FSGS patients compared to those in MCD ones was observed. This study suggests that urinary exosomal miR-193a may be a new noninvasive biomarker for the diagnosis of primary FSGS.

Citing Articles

Future embracing: exosomes driving a revolutionary approach to the diagnosis and treatment of idiopathic membranous nephropathy.

Wang L, Wang J, Xu A, Wei L, Pei M, Shen T J Nanobiotechnology. 2024; 22(1):472.

PMID: 39118155 PMC: 11312222. DOI: 10.1186/s12951-024-02633-y.

Non-Invasive Biomarkers for Diagnosis, Risk Prediction, and Therapy Guidance of Glomerular Kidney Diseases: A Comprehensive Review.

Catanese L, Rupprecht H, Huber T, Lindenmeyer M, Hengel F, Amann K Int J Mol Sci. 2024; 25(6).

PMID: 38542491 PMC: 10970781. DOI: 10.3390/ijms25063519.

Precision medicine for focal segmental glomerulosclerosis.

Xie Y, Liu F Kidney Res Clin Pract. 2024; 43(6):709-723.

PMID: 38325863 PMC: 11615440. DOI: 10.23876/j.krcp.23.227.

MicroRNA193a: An Emerging Mediator of Glomerular Diseases.

Bharati J, Kumar M, Kumar N, Malhotra A, Singhal P Biomolecules. 2023; 13(12).

PMID: 38136614 PMC: 10742064. DOI: 10.3390/biom13121743.

Urinary extracellular vesicles in childhood kidney diseases.

Harita Y Pediatr Nephrol. 2023; 39(8):2293-2300.

PMID: 38093081 PMC: 11199279. DOI: 10.1007/s00467-023-06243-y.

References

Lv L, Cao Y, Pan M, Liu H, Tang R, Ma K . CD2AP mRNA in urinary exosome as biomarker of kidney disease. Clin Chim Acta. 2013; 428:26-31. DOI: 10.1016/j.cca.2013.10.003. View

Wang J, Yang B, Han L, Li X, Tao H, Zhang S . Demethylation of miR-9-3 and miR-193a genes suppresses proliferation and promotes apoptosis in non-small cell lung cancer cell lines. Cell Physiol Biochem. 2013; 32(6):1707-19. DOI: 10.1159/000356605. View

Kwon J, Kim B, Kwak S, Bae I, Han Y . Ionizing radiation-inducible microRNA miR-193a-3p induces apoptosis by directly targeting Mcl-1. Apoptosis. 2013; 18(7):896-909. DOI: 10.1007/s10495-013-0841-7. View

Alvarez M . Isolation of urinary exosomes for RNA biomarker discovery using a simple, fast, and highly scalable method. Methods Mol Biol. 2014; 1182:145-70. DOI: 10.1007/978-1-4939-1062-5_13. View

Kietzmann L, Guhr S, Meyer T, Ni L, Sachs M, Panzer U . MicroRNA-193a Regulates the Transdifferentiation of Human Parietal Epithelial Cells toward a Podocyte Phenotype. J Am Soc Nephrol. 2014; 26(6):1389-401. PMC: 4446868. DOI: 10.1681/ASN.2014020190. View

Thomas R, Roberts D, Kubli D, Lee Y, Quinsay M, Owens J . Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure. Genes Dev. 2013; 27(12):1365-77. PMC: 3701192. DOI: 10.1101/gad.215871.113. View

DAgati V, Kaskel F, Falk R . Focal segmental glomerulosclerosis. N Engl J Med. 2011; 365(25):2398-411. DOI: 10.1056/NEJMra1106556. View

Gamez-Valero A, Lozano-Ramos S, Bancu I, Lauzurica-Valdemoros R, Borras F . Urinary extracellular vesicles as source of biomarkers in kidney diseases. Front Immunol. 2015; 6:6. PMC: 4311634. DOI: 10.3389/fimmu.2015.00006. View

Chandrasekaran K, Karolina D, Sepramaniam S, Armugam A, Wintour E, Bertram J . Role of microRNAs in kidney homeostasis and disease. Kidney Int. 2012; 81(7):617-27. DOI: 10.1038/ki.2011.448. View

10.

Granato M, Chiozzi B, Filardi M, Lotti L, Di Renzo L, Faggioni A . Tyrosine kinase inhibitor tyrphostin AG490 triggers both apoptosis and autophagy by reducing HSF1 and Mcl-1 in PEL cells. Cancer Lett. 2015; 366(2):191-7. DOI: 10.1016/j.canlet.2015.07.006. View

11.

Kawakami T, Gomez I, Ren S, Hudkins K, Roach A, Alpers C . Deficient Autophagy Results in Mitochondrial Dysfunction and FSGS. J Am Soc Nephrol. 2014; 26(5):1040-52. PMC: 4413752. DOI: 10.1681/ASN.2013111202. View

12.

Ramezani A, Devaney J, Cohen S, Wing M, Scott R, Knoblach S . Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study. Eur J Clin Invest. 2015; 45(4):394-404. PMC: 4903079. DOI: 10.1111/eci.12420. View

13.

Gebeshuber C, Kornauth C, Dong L, Sierig R, Seibler J, Reiss M . Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Nat Med. 2013; 19(4):481-7. DOI: 10.1038/nm.3142. View

14.

Schena F, Sallustio F, Serino G . microRNAs in glomerular diseases from pathophysiology to potential treatment target. Clin Sci (Lond). 2015; 128(11):775-88. DOI: 10.1042/CS20140733. View

15.

Hogan M, Johnson K, Zenka R, Charlesworth M, Madden B, Mahoney D . Subfractionation, characterization, and in-depth proteomic analysis of glomerular membrane vesicles in human urine. Kidney Int. 2013; 85(5):1225-37. PMC: 4008663. DOI: 10.1038/ki.2013.422. View

16.

Taylor D, Shah S . Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. Methods. 2015; 87:3-10. DOI: 10.1016/j.ymeth.2015.02.019. View

17.

Zhang C, Zhang W, Chen H, Liu C, Wu J, Shi S . Plasma microRNA-186 and proteinuria in focal segmental glomerulosclerosis. Am J Kidney Dis. 2014; 65(2):223-32. DOI: 10.1053/j.ajkd.2014.07.013. View

18.

Taylor D, Zacharias W, Gercel-Taylor C . Exosome isolation for proteomic analyses and RNA profiling. Methods Mol Biol. 2011; 728:235-46. DOI: 10.1007/978-1-61779-068-3_15. View

19.

Braicu C, Tomuleasa C, Monroig P, Cucuianu A, Berindan-Neagoe I, Calin G . Exosomes as divine messengers: are they the Hermes of modern molecular oncology?. Cell Death Differ. 2014; 22(1):34-45. PMC: 4262777. DOI: 10.1038/cdd.2014.130. View

20.

Germain M, Slack R . MCL-1 regulates the balance between autophagy and apoptosis. Autophagy. 2011; 7(5):549-51. DOI: 10.4161/auto.7.5.15098. View